Quote:psychoactive medicines
correction.psychoactive drugs.
if the purpose is a research to be done on this don't upgrade them just yet.There is a major difference between drug and medicine.The second has been tested over and over while the first has come directly from nature if it's not chemical.
Moreover i don't really understand how a pressure for others to use them can lead to a research(could someone explain the..plan?!).
And bonkers it is pressure cause you just didn't even bother to ask kim what treatments has already done and what not, as there are chronic who are resistant to treatments and episodics who might get relief from the same as it seems that there are major differences between clusterheads(medical literature)
Finally at the other topic here -75% stand up- i only see updates of how succesful it is and pf makes while i ve never read anything here not even for a slight side effect while on clusterbusters has been mentioned(trip).
two articles for whoever wants to read.
Multimedia File Viewing and Clickable Links are available for Registered Members only!! You need to

or

Multimedia File Viewing and Clickable Links are available for Registered Members only!! You need to

or

; *
Quote:Psilocin mainly interacts with 5-HT1A, 5-HT2A and 5-HT2C receptor subtypes: it is a mixed receptor agonist. In contrast to LSD, psilocin does not have an effect on the dopamine receptor. Tryptamines and phenethylamine hallucinogens both have a relatively high affinity for serotonin 5-HT2 receptors, but they differ in their affinity for other subtypes of serotonin receptors. The correlation between the relative affinity of hallucinogens for 5-HT2-receptors and their potency as hallucinogens in human beings suggest that an important component of the mechanism of action of these substances is through stimulation of brain 5-HT2-receptors. A primary role for the 5-HT2-receptor in the mechanism of hallucinations is further suggested by the observation that antagonists of the 5-HT2-receptor are effective in blocking the behavioural and electrophysiological effects of hallucinogenic drugs in animals and in man. Although 5HT2-receptors are certainly involved, at present, it is not possible to attribute the psychedelic effects to any single 5-HT receptor subtype.
Behavioural effects are dependent on dose and the individual reaction and sensitivity to psilocybin, previous experiences and the setting. The major effects are related to the central nervous system, but there are also some sympathomimetic effects. The subjective effects, however, may vary greatly between individuals and from one episode of use to the next within the same person. The effects range from mild feelings of relaxation, giddiness, euphoria, visual enhancement (seeing colours brighter), visual disturbances (moving surfaces, waves), to delusions, altered perception of real events, images and faces, or real hallucinations. The sensory distortions may be coupled with restlessness, incoordination, feelings of anxiety, impaired judgement of time or distance, sense of unreality or even depersonalisation. These effects may be termed 'bad trips' by users and can also involve panic reactions and psychosis-like states.
In general, the physiological effects are not significant, but may include dizziness, nausea, weakness, muscle aching, shivering, abdominal pain, dilation of pupils (mydriasis), mild-to-moderate increase in heart rate (tachycardia) and breathing (tachypnea) and elevation of blood pressure. Generally, body temperature remains normal. However, pronounced physical symptoms such as severe stomach pain, persistent vomiting, diarrhoea etc. have been recorded
ever question why are illegal?
* Multimedia File Viewing and Clickable Links are available for Registered Members only!! You need to

or